Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
A long week or a long night
Legal Limbo: How the FDAs Decision Could Reshape the Weight Loss Drug Market The regulatory framework enabling Hims & Hers GLP-1 business rests on the FDAs drug shortage designations
In March 2026, Structure reported 44-week topline data from the ACCESS II Phase 2 study, showing placebo-adjusted weight loss of up to 16.3%, which the company described as the highest efficacy demonstrated among oral GLP-1 receptor agonists at that time point
For individuals, moving from a systolic reading of 138 to 131 moves them from the Stage 1 hypertension category toward the high-normal range, a meaningful clinical milestone even before factoring in weight change
US$ 26.19
US$ 25.62
US$ 24.42
US$ 23.31
US$ 20.23
US$ 29.85
US$ 27.67
US$ 21.04
US$ 21.48
US$ 20.12
US$ 21.70
US$ 28.16
US$ 25.58
US$ 26.57
US$ 25.40
